Na Xu

Research progress on emerging programmed cell death pathways in osteosarcoma therapy

Osteosarcoma is a prevalent malignant bone tumor in adolescents. For decades, clinical management has been hampered by two major challenges: chemoresistance and a high metastasis rate, resulting in persistently poor survival outcomes. Conventional therapies primarily focus on ind...